CoFix RX is a Nasal Liquid in the Human Otc Drug category. It is labeled and distributed by Lxr Biotech Llc. The primary component is Povidone-iodine.
| Product ID | 78299-221_c1226d9a-a529-79c2-e053-2995a90af018 |
| NDC | 78299-221 |
| Product Type | Human Otc Drug |
| Proprietary Name | CoFix RX |
| Generic Name | Povidone-iodine Antiviral Nasal Spray |
| Dosage Form | Liquid |
| Route of Administration | NASAL |
| Marketing Start Date | 2021-04-29 |
| Marketing Category | OTC MONOGRAPH NOT FINAL / |
| Application Number | part333E |
| Labeler Name | LXR Biotech LLC |
| Substance Name | POVIDONE-IODINE |
| Active Ingredient Strength | 1 mg/100mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-04-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 78299-211 | CoFix RX | Povidone-Iodine Antiviral Nasal Spray |
| 78299-221 | CoFix RX | Povidone-Iodine Antiviral Nasal Spray |
| 81906-211 | CoFix RX | Povidone-Iodine Antiviral Nasal Spray |
| 81906-221 | CoFix RX | Povidone-Iodine Antiviral Nasal Spray |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() COFIX RX 90337951 not registered Live/Pending |
CoFix-RX, LLC 2020-11-23 |